Active Ingredient: NIFEDIPINE
Proprietary Name: AFEDITAB CR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075128
Product Number: 001
Approval Date: Mar 10, 2000
Applicant Holder Full Name: WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information